STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA

NACompletedINTERVENTIONAL
Enrollment

554

Participants

Timeline

Start Date

September 11, 2019

Primary Completion Date

July 24, 2024

Study Completion Date

July 24, 2024

Conditions
HematuriaUrothelial Carcinoma
Interventions
DIAGNOSTIC_TEST

Cxbladder

"The Cxbladder Triage test result will be provided to physicians for all low risk subjects on the test arm. If a low risk subject has a Cxbladder Triage negative test result then the indication is to rule out the subject without further assessment. The decision to rule-out or further evaluate is solely that of the physician and subject. If the low risk subjects are not Cxbladder Triage negative then a Cxbladder Detect test result will also be provided. The indication is further evaluation as per standard of care. Not low risk patients will be evaluated as per standard of care."

Trial Locations (12)

29572

Carolina Urologic Research Center, Myrtle Beach

34787

Avant Concierge Urology, Winter Garden

37232

Department of Urology,Vanderbilt University, Nashville

55455

University of Minnesota, Department of Urology, Minneapolis

60515

Accellacare, Chicago

75390

UT Southwestern Medical Center, Dallas

78229

UTHSA - Mays Cancer Center, San Antonio

90089

Institute of Urology, USC Norris Comprehensive Cancer Center, Los Angeles

55407-3799

Allina Health Cancer Institute, Minneapolis

17033-0850

Division of urology, Penn State Milton S Hershey Medical Center, Hershey

V5Z1M9

The prostate centre- Diamond Health care centre, Vancouver

N6A5W9

London Health Sciences Centre Victoria Hospital, London

Sponsors
All Listed Sponsors
lead

Pacific Edge Limited

INDUSTRY

NCT03988309 - STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA | Biotech Hunter | Biotech Hunter